Published on
January 2, 2024
- 17:30 GMT
Accurius Therapeutics to Present at Upcoming Biotech Showcase™
Oncolytic Immunotherapy developer to preview novel oncolytic virus targeted at lung cancer BOSTON, MA, US, January 2, 2024 /EINPresswire.com/ -- Accurius Therapeutics, a developer of highly targeted oncolytic immunotherapies, is pleased to announce that …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
